Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Vaxcyte Inc (PCVX)

Vaxcyte Inc (PCVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,708,286
  • Shares Outstanding, K 108,408
  • Annual Sales, $ 0 K
  • Annual Income, $ -402,270 K
  • 60-Month Beta 0.89
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.97
Trade PCVX with:

Options Overview Details

View History
  • Implied Volatility 52.89% ( -1.29%)
  • Historical Volatility 35.09%
  • IV Percentile 75%
  • IV Rank 52.59%
  • IV High 72.42% on 04/14/23
  • IV Low 31.23% on 12/12/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 6
  • Volume Avg (30-Day) 168
  • Put/Call OI Ratio 1.17
  • Today's Open Interest 6,031
  • Open Int (30-Day) 6,243

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -1.11
  • Number of Estimates 3
  • High Estimate -1.00
  • Low Estimate -1.24
  • Prior Year -0.70
  • Growth Rate Est. (year over year) -58.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
60.55 +2.20%
on 04/12/24
73.57 -15.89%
on 03/13/24
-9.74 (-13.60%)
since 03/12/24
3-Month
59.45 +4.09%
on 01/16/24
82.04 -24.57%
on 02/28/24
+1.16 (+1.91%)
since 01/12/24
52-Week
34.56 +79.03%
on 04/13/23
82.04 -24.57%
on 02/28/24
+27.09 (+77.87%)
since 04/12/23

Most Recent Stories

More News
Biotech Stock Roundup: MDGL, PCVX Up on Study Data, MRNA Provides Updates

Pipelines updates from Madrigal (MDGL) and Vaxcyte, (PCVX) are the key highlights of the biotech sector.

GSK : 40.66 (-0.34%)
MRK : 125.74 (-0.33%)
MRNA : 105.14 (-1.75%)
MDGL : 236.59 (-3.54%)
PCVX : 61.88 (-4.55%)
Vaxcyte (PCVX) Up on Pneumococcal Conjugate Vaccine Data

Vaxcyte (PCVX) announces positive results from the mid-stage study of its 24-Valent pneumococcal conjugate vaccine candidate, VAX-24, in adults aged 65 and older.

PFE : 25.86 (-1.82%)
NVO : 124.51 (-0.71%)
LGND : 81.36 (-0.09%)
PCVX : 61.88 (-4.55%)
Still 50% Upside To Go, Wall Street Is Getting Vaxcyte Right

When a biotech company delivers chart-busting news, more often follows. In a space that can be like throwing darts, Wall Street has bullseyes on Vaxcyte, Inc.

PCVX : 61.88 (-4.55%)
PFE : 25.86 (-1.82%)
MRK : 125.74 (-0.33%)
Why Investors Are Suddenly Excited About Vaxcyte

Vaxcyte, Inc. is a small cap biotech company that catapulted back to mid-cap land with a stunning 110% surge — and may not be done yet.

PCVX : 61.88 (-4.55%)
PFE : 25.86 (-1.82%)
MRNA : 105.14 (-1.75%)
STRO : 4.14 (-8.00%)
MRK : 125.74 (-0.33%)
Why Shares of Vaxcyte Rose 110.7% This Week

The company released early data for a promising pneumonia vaccine.

PFE : 25.86 (-1.82%)
PCVX : 61.88 (-4.55%)
Recent Price Trend in Vaxcyte, Inc. (PCVX) is Your Friend, Here's Why

Vaxcyte, Inc. (PCVX) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through...

PCVX : 61.88 (-4.55%)
Vaxcyte, Myovant rise; Dorman, Shift4 Payments fall

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday:

DORM : 90.05 (-2.31%)
TSLA : 171.05 (-2.03%)
MYOV : 26.98 (-0.04%)
PCVX : 61.88 (-4.55%)
SCHL : 35.76 (-1.62%)
FOUR : 63.98 (-4.15%)
Incyte Announces Agreement to Acquire Medicxi-backed Villaris Therapeutics and Auremolimab (VM6), an Anti-IL-15Rβ Monoclonal Antibody

Incyte (NASDAQ:INCY) today announced that the Company has entered into an agreement to acquire Villaris Therapeutics, an asset-centric biopharmaceutical company seeded by Medicxi and focused on the development...

INCY : 53.85 (-1.95%)
MOLN : 3.95 (+2.33%)
PCVX : 61.88 (-4.55%)
AURA : 7.54 (-2.08%)
CNTA : 11.32 (-4.63%)
Vaxcyte Reports Second Quarter 2022 Financial Results and Provides Business Update

-- Completed Enrollment of Phase 2 Portion of Phase 1/2 Clinical Proof-of-Concept Study Evaluating Safety, Tolerability and Immunogenicity of VAX-24 in...

PCVX : 61.88 (-4.55%)
Vaxcyte (PCVX) Completes Enrollment in Pneumococcal Disease Study

Vaxcyte (PCVX) enrolls the last patient in the phase II portion of phase I/HH study, evaluating VAX-24 for preventing invasive pneumococcal disease and pneumonia in healthy adults.

MRK : 125.74 (-0.33%)
SGEN : 228.74 (-0.07%)
AQST : 3.91 (-4.40%)
PCVX : 61.88 (-4.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Vaxcyte Inc.is a biopharmaceutical company develops vaccines for infectious diseases. It offers conjugate, pneumococcal conjugate and complex antigen-based vaccines. Vaxcyte Inc.is based in Foster City, California.

See More

Key Turning Points

3rd Resistance Point 68.12
2nd Resistance Point 66.34
1st Resistance Point 64.11
Last Price 61.88
1st Support Level 60.10
2nd Support Level 58.32
3rd Support Level 56.09

See More

52-Week High 82.04
Fibonacci 61.8% 63.90
Last Price 61.88
Fibonacci 50% 58.30
Fibonacci 38.2% 52.70
52-Week Low 34.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar